Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters
Open Access

The potential benefits of a national vaccine registry for Canada

Iris S. Gorfinkel and Joel Lexchin
CMAJ May 31, 2021 193 (22) E808; DOI: https://doi.org/10.1503/cmaj.78920
Iris S. Gorfinkel
General practitioner, vaccine researcher, founder and principal investigator, PrimeHealth Clinical Research, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel Lexchin
Professor emeritus, School of Health Policy and Management, York University; emergency physician, Department of Emergency Medicine, University Health Network, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

The article by Duong about the vaccine rollout didn’t deal with a key deficiency in Canada’s vaccine strategy.1 Canada continues to lack a centralized tracking system for SARS-CoV-2 vaccines. Instead, reliance is placed on a patchwork of provincial and territorial systems that are unable to communicate with Health Canada or with one another.2

Health Canada lacks vital information about population-specific vaccination rates that a national vaccine registry would provide. As a direct result, the Public Health Agency of Canada can neither compare the relative effectiveness of vaccines in different populations nor evaluate how effective each vaccine is against specific emerging variants.

A national vaccine registry would provide real-time insight into vaccine effectiveness that would prove critical to a more rapid return to normalcy. The added knowledge would enable a more agile and nuanced response to this and future outbreaks based on real-world, Canadian-specific data. This information is especially crucial when vaccine supply is limited.

Health Canada is currently siloed from the reporting on adverse events collected by the provinces and territories. 3 A robust national vaccine registry would also serve as a Canada-wide repository of uncommon adverse events. The safety of vaccines within Canada’s diverse populations is best understood from data mined directly from Canada’s provinces and territories rather than data mainly collected outside Canada.

Finally, combining provincial and territorial data to form a robust national vaccine registry would enable the National Advisory Committee on Immunizations to better determine the ideal interval between vaccine doses and match specific vaccines to particular variants of concern.

Yet despite the many advantages of a national vaccine registry, the implicit stance of the provinces and territories is, in fact, not to share data.4 The need for coordinated and integrated tracking systems was demonstrated by the severe acute respiratory syndrome (SARS) epidemic in 2003, after which the federal government funded Panorama to be able to manage vaccine inventory, track vaccines and adverse events, perform contact tracing and, critically, become a tool to investigate outbreaks.4 But by 2015, the conclusion was that Panorama was not user friendly and was hard to navigate and prone to errors.5

A national vaccine registry should be created from vaccine information collected by the provinces and territories. Political will to do so at all levels of government is needed, along with commitment to ensuring the necessary resources.

Critical information is not being analyzed, even as hospital admissions and death tallies rise. The immediate creation of a national vaccine registry would save lives and prevent suffering by enabling Health Canada to provide evidence-based recommendations informed by timely, real-world, Canadian-specific data.

Footnotes

  • Competing interests: Iris Gorfinkel reports receiving research grants from GSK, Merck, Mundipharma, Johnson & Johnson and Urovant. Dr. Gorfinkel has also received payment for lectures from GSK and CME Outfitters, and speaker fees from CBC and CTV. She has served as co-chair of the Advisory Board for Shingrix (GSK Canada). Joel Lexchin reports receiving consulting fees from Michael F. Smith, Lawyer, and Goodmans LLP. Dr. Lexchin has also received payment for being part of panels for the American Diabetes Association and Canadian Institutes of Health Research, and speaker fees from Toronto Reference Library. He is a member of the Foundation Board of Health Action International and the Board of Canadian Doctors for Medicare. He receives royalties from University of Toronto Press and James Lorimer & Co. Ltd. for books he has written.

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

References

  1. ↵
    1. Duong D
    . Canadian physicians frustrated with vaccine rollout. CMAJ 2021;193:E458–9.
    OpenUrlFREE Full Text
  2. ↵
    Vaccination coverage in Canada. Ottawa: Government of Canada; 2019. Available: www.canada.ca/en/public-health/services/immunization-vaccines/vaccination-coverage.html (accessed 2021 Apr. 5)
  3. ↵
    Canada’s Health Care System. Ottawa: Government of Canada; 2019. Available: www.canada.ca/en/health-canada/services/health-care-system/reports-publications/health-care-system/canada.html (accessed 2021 Apr. 5)
  4. ↵
    1. Ling J
    . Provinces are working with outdated vaccine tracking systems, hindering national data. Globe and Mail [Toronto]. Available: www.theglobeandmail.com/canada/article-provinces-working-with-outdated-vaccine-tracking-systems/ (accessed 2021 Apr. 5)
  5. ↵
    An audit of the Panorama public health system. Victoria, BC: Office of the Auditor General of British Columbia; 2015. Available: www.bcauditor.com/sites/default/files/publications/reports/OAGBC_PanoramaReport_FINAL.pdf (accessed 2021 Apr. 5)
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 193 (22)
CMAJ
Vol. 193, Issue 22
31 May 2021
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The potential benefits of a national vaccine registry for Canada
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The potential benefits of a national vaccine registry for Canada
Iris S. Gorfinkel, Joel Lexchin
CMAJ May 2021, 193 (22) E808; DOI: 10.1503/cmaj.78920

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
The potential benefits of a national vaccine registry for Canada
Iris S. Gorfinkel, Joel Lexchin
CMAJ May 2021, 193 (22) E808; DOI: 10.1503/cmaj.78920
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • Canadian physicians frustrated with vaccine rollout
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Beyond wastewater surveillance: refining environmental pathogen detection in the built environment
  • Observational evidence in support of screening for depression during pregnancy and the postpartum period
  • Providers need guidance on managing perinatal mental health
Show more Letters

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire